Position in ALNY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$126,894,380
+$270,101 QoQ
Shares Held
421,534
+10.1% QoQ
Ownership
0.315%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#45
of 784 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FIRST TRUST ADVISORS LP holds $2,824,813,122 across 97 Biotechnology names. ALNY ranks #6 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
547,132 | $341,158,687 | |
| 2 | INCY |
Incyte Corp
|
1,587,996 | $180,015,226 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
1,829,545 | $159,078,937 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
289,179 | $143,643,884 | |
| 5 | EXEL |
Exelixis, Inc.
|
2,543,353 | $138,383,836 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
421,534 | $126,894,380 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
324,900 | $120,755,583 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
482,061 | $117,994,070 |
All Filings in ALNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $126,894,380 | 421,534 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $126,624,279 | 382,701 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $102,177,758 | 256,954 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $95,934,648 | 210,383 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $82,115,005 | 251,817 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $48,727,809 | 180,460 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $77,130,382 | 327,782 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $78,540,592 | 285,571 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $58,452,921 | 240,547 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $32,486,394 | 217,373 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $58,704,107 | 306,693 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $41,351,079 | 233,490 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $52,494,857 | 276,376 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $86,155,027 | 430,087 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $99,946,084 | 420,560 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $99,065,589 | 494,932 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $58,320,310 | 399,865 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $65,749,045 | 402,652 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $85,993,339 | 507,096 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $100,500,919 | 532,286 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $85,764,066 | 505,923 | Shares | Sole | 2021-10-12 | |
| 2021-03-31 | $61,012,434 | 432,130 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $73,124,371 | 562,625 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $105,649,107 | 725,612 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $119,904,820 | 809,566 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $92,221,420 | 847,234 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||